Vygon, an Écouen, France-based specialist single-use medical devices company, tookover Advanced Perfusion Diagnostics, a Lyon, France-based startup specializing in the development of innovative monitoring solutions for critical care and the operating room.
The financial terms of the agreement have not been disclosed. The takeover includes technology, patents and the onboarding of APD’s staff.
Founded in 2014, APD has developed IKORUS®, a device that detects changes in visceral microvascular blood flow in the most critically ill hospital patients. IKORUS, which addresses an unmet need in anesthesia and critical care, obtained CE marking in June 2019, enabling the launch of an expanded clinical trial phase with several leading European centers.
IKORUS, combined with the IKORUS UP Foley catheter, introduces a new indicator known as ‘uPI’, the urethral Perfusion Index. The ‘intelligent’ catheter leverages a sensor, which is affixed to the wall of the urethra and helps evaluate the quality of the microvascular blood flow. The use of IKORUS in conjunction with Vygon’s critical care offering provides physicians – and patients – with a complete monitoring solution for both macrovascular and microvascular blood flow, using an identical approach that combines sterile medical devices and monitors.
Led by Stéphane Regnault, CEO, Vygon designs, manufactures and markets high-tech single-use medical devices for healthcare professionals in hospital and for private and independent practitioners. It is offering a wide range of products in a number of clinical specialties. Organized in five business units (Critical Care – Obstetrics Neonatology Enteral – Intravascular Therapies – Cardiovascular & Surgery – Anesthesia & Emergency), the company distributes over 205 million products a year in more than 120 countries through its network of 26 subsidiaries and 331 distributors.
Vygon products display the CE and/or FDA mark and are manufactured in the group’s eight factories in Europe, the USA and Colombia.
A family company founded in 1962, the mid-sized business employs 2,350 staff worldwide. Turnover in 2018 was €323 million ($360M), with 81% of this derived from Vygon’s international business.